The eighth edition of the Palliative Care Formulary (PCF), from Pharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business, is an essential resource for health professionals who care for patients with progressive end-stage disease.
Although written primarily with cancer patients in mind, PCF8 contains specific material relating to several other life-limiting diseases e.g. COPD, end-stage heart failure, renal and hepatic failure, and end-stage Parkinson's disease.
PCF8 also includes several Quick Clinical Guides covering key topics in palliative care and designed for everyday use.
Grounded in clinical practice, this comprehensive title includes independent information about drugs used in palliative care, highlighting off-label indications or routes, and dealing with the administration of multiple drugs by continuous subcutaneous infusion.
PCF8 consists of 35 chapters and appendices; of the monographs, there is one renamed (Tricyclic antidepressants) and two discontinued (Carbamazepine and Danazol).
Key monographs in PCF8 have been fully reviewed and revised for this edition, including all analgesics, antidepressants, bisphosphonates, denosumab, drugs and fitness to drive, renal impairment and swallowing difficulties and enteral feeding tubes.